Evidence-Based Complementary and Alternative Medicine / 2012 / Article / Tab 1

Research Article

Uncaria tomentosa—Adjuvant Treatment for Breast Cancer: Clinical Trial

Table 1

Clinical characteristic of patients. It represents age, body mass index (BMI), total cholesterol levels, estrogen receptor (ER), and progesterone receptors (PR), as well as the HER-2 status in different groups.

Clinical parametersControl Ca UtCa

Age interval32–7932–7140–75
Mean age
Cholesterol levels
Estrogen receptor status (ER)
Progesterone receptor status (PR)
HER-2 receptor status (HER2)*

The results for ER, HER2, and REP are represented as positive and negative numbers for the expression of receptors by number of women, while other parameters are expressed as mean ± standard deviation. UtCa group: patients treated with chemotherapy +300 mg Uncaria tomentosa daily ; Ca group: patients received chemotherapy ; control group .
*To HER-2 receiver only data were obtained from 18 patients.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.